Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–2 of 2 results
Advanced filters: Author: Mélanie Desbois Clear advanced filters
  • The exclusion of T cells from solid tumours is a potentially important mechanism that regulates whether or not cancer patients respond well to checkpoint blocking immunotherapies. Here the authors identify immune phenotypes and mediators of T cell exclusion among ovarian cancer patient samples from the ICON7 phase III trial.

    • Mélanie Desbois
    • Akshata R. Udyavar
    • Yulei Wang
    ResearchOpen Access
    Nature Communications
    Volume: 11, P: 1-14
  • The gut microbiota has been reported to regulate the efficacy of cancer therapy. Here, the authors show that short-chain fatty acids, which are generated through bacterial fermentation, increases immune tolerance leading to resistance to anti-CTLA-4 immunotherapy in mice and patients with metastatic melanoma.

    • Clélia Coutzac
    • Jean-Mehdi Jouniaux
    • Nathalie Chaput
    ResearchOpen Access
    Nature Communications
    Volume: 11, P: 1-13